From: The downregulation of NCXs is positively correlated with the prognosis of stage II–IV colon cancer
Characteristics | HR | Univariate CI (95%) | P | HR | Multivariate CI (95%) | P |
---|---|---|---|---|---|---|
Sex | ||||||
(Male/female) | 1.075 | 0.602, 0.337 | 0.086 | 0.774 | 0.419, 1.427 | 0.411 |
Age, years | ||||||
(≥ 60/< 60) | 0.883 | 0.022, 1 | 0.883 | 0.87 | 0.473, 1.599 | 0.653 |
TNM stage | ||||||
T stage | 2.584 | 1.601, 0.992 | < 0.05* | 1.779 | 1.019, 3.106 | < 0.05* |
N stage | 10.801 | 5.501, 2.801 | < 0.01** | 2.285 | 1.057, 4.938 | < 0.05* |
M stage | 13.214 | 7.309, 4.043 | < 0.01** | 2.984 | 1.594, 5.587 | < 0.01** |
Differentiation degree | ||||||
(high/medium/low) | 3.141 | 1.924, 1.178 | < 0.05* | 0.801 | 0.442, 1.451 | 0.464 |
Tumor size | ||||||
(≥ 5 cm/< 5 cm) | 1.295 | 0.762, 0.448 | 0.315 | 1.491 | 0.755, 2.944 | 0.25 |
CEA | ||||||
(Positive/negative) | 0.996 | 0.578, 0.336 | < 0.05* | 0.778 | 0.421, 1.44 | 0.425 |
NCX1 | ||||||
(Tumor/normal) | 0.277 | 0.099, 0.036 | < 0.01** | 0.145 | 0.049, 0.43 | < 0.01** |
NCX2 | ||||||
(Tumor/normal) | 0.422 | 0.132, 0.041 | < 0.01** | 0.187 | 0.056, 0.628 | < 0.01** |
NCX3 | ||||||
(Tumor/normal) | 0.357 | 0.087, 0.021 | < 0.01** | 0.215 | 0.05, 0.936 | < 0.05* |